Imbria Pharmaceuticals

Drug Discovery · Boston, MA · Founded 2018 · Privately Held (backing)

Operator of a clinical-stage company designed to develop novel therapies for patients with life-altering cardiometabolic disorders. Imbria Pharmaceuticals is based in Boston, MA and was founded in 2018. It was valued at $132 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $152 million across 2 recorded rounds; the latest was a $66.7 million Series B in Dec 2025.

PMV mark · valuation
$131.7M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$151.9M
Last round
Later Stage VC (Series B)
Dec 2025
How much has Imbria Pharmaceuticals raised?
$151.9Macross 2 recorded rounds · Jun 2020 – Dec 2025

Most recently, Imbria Pharmaceuticals raised $66.7M in its Later Stage VC (Series B) (Dec 2025).

Free account
More of Imbria Pharmaceuticals with a free account
  • ·Watch Imbria Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Imbria Pharmaceuticals round by round

2 rounds
Dec 2025Later Stage VC (Series B)$66.7M▮
+ 1 more investors · free account
Jun 2020Early Stage VC$40.7MSEC filing▮
4 investors participated

How much has Imbria Pharmaceuticals raised?

Imbria Pharmaceuticals has raised $152 million in total; 2 of its rounds are on record. The largest on record was a $66.7 million Series B in Dec 2025.

Imbria Pharmaceuticals has filed 2 Form Ds with the SEC since 2020, most recently in Apr 2025 ($59.2 million sold to 8 investors).

Imbria Pharmaceuticals investors

9 investors are on record for Imbria Pharmaceuticals, including RA Capital Management, Catalio Capital Management, SV Health Investors and Deep Track Capital. The Series B in Dec 2025 drew 6 investors.

For fundraisers
Raising for a company like Imbria Pharmaceuticals?

9 investors have backed Imbria Pharmaceuticals — start your target list with the firms already writing checks in drug discovery.

See all 9 investors →

Frequently asked about Imbria Pharmaceuticals

How much has Imbria Pharmaceuticals raised?
Imbria Pharmaceuticals has raised $151.9M in total across 2 recorded funding rounds.
When was Imbria Pharmaceuticals's last funding round?
Imbria Pharmaceuticals's most recent recorded round was Later Stage VC (Series B) in Dec 2025, raising $66.7M.